Edward P. Feener Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Edward P. Feener.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Edward P. Feener. Edward P. Feener is Chief Scientific Officer in KalVista Pharmaceuticals, Inc. ($CBYL).
Latest Insider Trading Transactions of Edward P. Feener
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | M | 10.21 | 6,000 | 61,260 | 20,255 | |
| May 06 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 24.84 | 6,000 | 149,051 | 54,234 | 60.2 K to 54.2 K (-9.96 %) |
| May 06 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Buy | M | 10.21 | 6,000 | 61,260 | 60,234 | 54.2 K to 60.2 K (+11.06 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 31.73 | 800 | 25,384 | 54,234 | 55 K to 54.2 K (-1.45 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 32.97 | 5,471 | 180,400 | 55,034 | 60.5 K to 55 K (-9.04 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 33.72 | 23,441 | 790,534 | 60,505 | 83.9 K to 60.5 K (-27.92 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 35.19 | 1,288 | 45,325 | 83,946 | 85.2 K to 83.9 K (-1.51 %) |
| Feb 08 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 10.20 | 20,000 | 204,000 | 20,000 | |
| Feb 08 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 24.23 | 22,500 | 545,175 | 22,500 | |
| Feb 08 2021 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Grant | A | 0.00 | 12,500 | 0 | 85,234 | 72.7 K to 85.2 K (+17.19 %) |
| Dec 18 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 10.20 | 65,000 | 663,000 | 65,000 | |
| Nov 04 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.14 | 6,000 | 102,812 | 72,734 | 78.7 K to 72.7 K (-7.62 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 18.75 | 5,407 | 101,374 | 78,734 | 84.1 K to 78.7 K (-6.43 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.65 | 3,600 | 63,554 | 84,141 | 87.7 K to 84.1 K (-4.10 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 18.00 | 2,300 | 41,407 | 87,741 | 90 K to 87.7 K (-2.55 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.26 | 5,600 | 96,683 | 90,041 | 95.6 K to 90 K (-5.86 %) |
| Oct 20 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.00 | 993 | 16,881 | 95,641 | 96.6 K to 95.6 K (-1.03 %) |
| Feb 07 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.11 | 100 | 1,711 | 96,634 | 96.7 K to 96.6 K (-0.10 %) |
| Jul 24 2019 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 18.65 | 1,900 | 35,439 | 96,734 | 98.6 K to 96.7 K (-1.93 %) |
| Jul 24 2019 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 18.57 | 1,400 | 26,004 | 98,634 | 100 K to 98.6 K (-1.40 %) |
| May 17 2019 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 24.23 | 20,250 | 490,658 | 20,250 | |
| Apr 18 2019 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 25.39 | 916 | 23,260 | 100,034 | 101 K to 100 K (-0.91 %) |
| Apr 18 2019 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 24.78 | 3,084 | 76,406 | 100,950 | 104 K to 101 K (-2.96 %) |
| Jan 18 2019 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 19.81 | 2,300 | 45,572 | 104,034 | 106.3 K to 104 K (-2.16 %) |
| Jan 18 2019 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 19.20 | 1,700 | 32,637 | 106,334 | 108 K to 106.3 K (-1.57 %) |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 16.08 | 52,600 | 845,808 | 52,600 | |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 16.08 | 52,600 | 845,808 | 52,600 | |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Payment of Exercise | F | 17.05 | 2,500 | 42,625 | 108,034 | 110.5 K to 108 K (-2.26 %) |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Payment of Exercise | F | 17.05 | 2,500 | 42,625 | 108,034 | 110.5 K to 108 K (-2.26 %) |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Grant | A | 0.00 | 12,500 | 0 | 110,534 | 98 K to 110.5 K (+12.75 %) |
| Sep 20 2018 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Grant | A | 0.00 | 12,500 | 0 | 110,534 | 98 K to 110.5 K (+12.75 %) |
| Jun 06 2018 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 8.21 | 51,800 | 425,278 | 51,800 | |
| May 26 2017 | CBYL | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 7.07 | 33,800 | 238,966 | 33,800 | |
| Nov 30 2016 | CBYL | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Option Exercise | A | 10.21 | 20,055 | 204,762 | 20,055 |
Page: 1